scholarly journals Declining Inpatient Mortality Despite Increasing Thirty-Day Readmissions of Alcoholic Hepatitis in the United States From 2010 to 2018

2021 ◽  
Vol 14 (6) ◽  
pp. 334-339
Author(s):  
Dushyant Singh Dahiya ◽  
Asim Kichloo ◽  
Jagmeet Singh ◽  
Gurdeep Singh ◽  
Farah Wani ◽  
...  
Keyword(s):  
United States ◽  
Alcoholic Hepatitis ◽  
The United States ◽  
Inpatient Mortality

Epidemiology, Clinical and Microbiologic Profile and Risk Factors for Inpatient Mortality in Pediatric Severe Sepsis in the United States From 2003 to 2014

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Aravind Thavamani ◽  
Krishna Kishore Umapathi ◽  
Harshitha Dhanpalreddy ◽  
Jasmine Khatana ◽  
Kobkul Chotikanatis ◽  
...  
Keyword(s):  
United States ◽  
Risk Factors ◽  
Severe Sepsis ◽  
The United States ◽  
Inpatient Mortality

scholarly journals SUN-054 The Impact of Gender on Inpatient Mortality of Hypertensive Patients across CKD Stage 3 to ESRD and Races in the United States

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Ghada Elshimy ◽  
Mark Abi Nader ◽  
Rodrigo Aguilar ◽  
Oussama Hassan Oussama Hassan ◽  
Carmen Elena Cervantes ◽  
...  
Keyword(s):  
United States ◽  
The United States ◽  
Inpatient Mortality ◽  
Hypertensive Patients ◽  
Ckd Stage ◽  
The Impact

In-hospital mortality in acute promyelocytic leukemia patients: A study of national inpatient sample.

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e18521-e18521
Author(s):  
Dipesh Uprety ◽  
Yazhini Vallatharasu ◽  
Amir Bista ◽  
Mamatha Gaddam ◽  
Andrew J Borgert ◽  
...  
Keyword(s):  
United States ◽  
Hospital Volume ◽  
Early Death ◽  
The United States ◽  
Promyelocytic Leukemia ◽  
Early Mortality ◽  
Matched Cohort ◽  
National Inpatient Sample ◽  
Inpatient Mortality ◽  
Icd 10

e18521 Background: Acute Promyelocytic Leukemia (APL), a subtype of acute myeloid leukemia, has excellent outcomes, but continues to show high rates of early mortality. An epidemiologic study utilizing SEER between 1992 & 2007 showed an early death rate of 17.3%. There is limited data on the incidence of inpatient mortality in APL patients in the United States and the factors that contribute to early death. Methods: National Inpatient Sample was utilized to identify adult patients (≥18 years) diagnosed with APL using International Classification of Diseases, 10th edition (ICD-10-CM) code C92.40. Since the United States transitioned from using ICD-9-CM to ICD-10-CM on October 2015, we included APL patients diagnosed between 2015 & 2016. Clinical, sociodemographic and hospital characteristic data were examined; hospital volume was divided into quartiles. The association between overall inpatient survival & receipt of chemotherapy was examined in a propensity score matched cohort of patients not discharged to another acute care facility. Statistical analyses were conducted utilizing SAS version 9.4. Results: In total, 433 APL patients were identified (median age 52 years, 52% males, 65% whites). The inpatient mortality rate was 9.93%. 59.5% (n = 258) of patients did not receive chemotherapy. On univariate-analysis, patients with younger age, black-race, transfer in from other hospital, elective admissions, private insurance, large bed size hospital & large hospital volume were more likely to receive chemo. In the matched-cohort, receipt of chemo was associated with decreased mortality (Hazard Ratio 0.27, 95% CI: 0.12-0.60). We ran additional mortality analysis landmarked at 3 days and 7 days: 75% of chemo patients receiving treatment within 3 days had survival advantage with chemo (HR: 0.35 [0.15-0.82]). 90% of chemo patients receiving treatment within 7 days didn’t show any difference in survival (HR: 0.49 [0.18-1.32]) but the sample size was small. Conclusions: Our study showed an early survival benefit when patient with APL received chemotherapy within 3 days of admission. Early recognition & prompt treatment initiation will help reduce the rate of early mortality in patients with APL.

scholarly journals Inpatient burden of esophageal cancer and analysis of factors affecting in-hospital mortality and length of stay

2018 ◽  
Vol 31 (9) ◽  
Author(s):  
S Sarvepalli ◽  
S K Garg ◽  
S S Sarvepalli ◽  
M P Parikh ◽  
V Wadhwa ◽  
...  
Keyword(s):  
United States ◽  
Esophageal Cancer ◽  
Length Of Stay ◽  
Clinical Decision Making ◽  
Hospital Admissions ◽  
The United States ◽  
Hospital Utilization ◽  
Inpatient Mortality ◽  
Factors Associated ◽  
Hospital Stays

Summary Esophageal cancer (EC) continues to be a major source of morbidity and mortality in the United States. However, there has been a relative dearth of research into hospital utilization in patients with EC. This study examines temporal trends in hospital admissions, length of stay (LOS), mortality, and costs associated with EC. In addition, we also analyzed factors associated with inpatient mortality and LOS. We interrogated National Inpatient Sample (NIS), a large registry of inpatient data, to retrieve information about various demographic and factors associated with hospital stay in patients who were admitted for EC between the years 1998 and 2013 in the United States. After examining trends over time, multivariate analysis was performed to identify factors associated with LOS and mortality. During 1998–2013, 538,776 hospital stays with principal diagnosis of EC were reviewed. Number of hospital stays and inpatient charges increased by 397 per year (±67.8;P < 0.0001) and $3,033 per patient per year (±135; <0.0001) respectively. Mortality and LOS decreased by 0.23% per year (±0.03;P < 0.0001) and 0.07 days per year (±0.006;P < 0.0001) respectively. Multiple factors associated with LOS and mortality were outlined. Despite overall increase in hospital utilization with respect to number of admissions and inpatient charges, inpatient mortality and LOS associated with EC declined. Factors associated with inpatient mortality and LOS may help drive clinical decision-making and influence healthcare or hospital policy.

Sign in / Sign up

Export Citation Format

Share Document